$HilleVax (HLVX.US)$ 🔥 TANG CAPITAL, a biomedical investmen...
$HilleVax(HLVX.US$ 🔥 TANG CAPITAL, a biomedical investment institution, took advantage of the sharp drop in stock prices and opened a 9.5% position this month. With the support of professional institutions, my venture capital position is more secure. Let's hope the clinical trials of the HIL-216 multivalent vaccine go well and there will be no more problems.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
北美深蓝 OP : The global viral gastroenteritis market is expected to reach $9.5 billion by 2032; 60% of viral gastroenteritis cases are caused by norovirus.
HIL-216 is another virus-like granular vaccine against norovirus and has been approved for development outside of China; compared to HIL-214, this vaccine can target more genotypes of norovirus.